Enchem (348370) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
24 Jun, 2026Executive summary
Specializes in manufacturing and selling electrolytes and additives for secondary batteries, with global operations and recent expansion into NMP recycling and joint ventures for solvent and lithium salt production.
Achieved rapid growth, with sales rising from 37 million KRW in 2012 to 424.7 billion KRW in 2023, and continued global expansion with new subsidiaries in Canada and France in 2024.
Holds a BB+ credit rating as of June 2024, reflecting recognized but somewhat unstable creditworthiness amid market uncertainties.
Financial highlights
Consolidated revenue for H1 2024 was 186.5 billion KRW, down from 424.7 billion KRW in H1 2023.
Operating loss for H1 2024 was 11.2 billion KRW, compared to an operating profit of 3.0 billion KRW in H1 2023.
Net loss attributable to controlling interests was 309.5 billion KRW for H1 2024, versus a net loss of 50.1 billion KRW in H1 2023.
Basic EPS for H1 2024 was -16,885 KRW, compared to -3,115 KRW in H1 2023.
Cash and cash equivalents at June 30, 2024, were 55.9 billion KRW, up from 44.6 billion KRW at year-end 2023.
Outlook and guidance
Expects continued growth in the global electrolyte market, driven by electric vehicle and energy storage demand.
Plans further expansion of overseas production capacity and entry into NMP recycling to secure raw material supply and cost competitiveness.
Latest events from Enchem
- Revenue fell and losses continued, raising material uncertainty about going concern.348370
Q2 2026 - 2024 Q3 saw steep revenue decline and heavy net loss, but global expansion and R&D continue.348370
Q3 2024 - Q1 2025 saw a sharp revenue drop but strong net profit from non-operating gains.348370
Q1 2025 - Net profit returned to positive despite lower sales, with global expansion and R&D ongoing.348370
Q3 2025 - 2023 saw a sharp swing to net loss on lower sales and higher costs, despite global expansion.348370
Q4 2025 - 2024 saw a steep revenue drop, heavy net loss, and major impairments amid persistent market risks.348370
Q4 2024 - Revenue declined and operating loss posted, but net profit achieved via non-operating gains.348370
Q2 2025